Detection of circulating tumor DNA in cerebrospinal fluid prior to diagnosis of spinal cord lymphoma by flow cytometric and cytologic analyses

Ann Hematol. 2022 May;101(5):1157-1159. doi: 10.1007/s00277-021-04686-7. Epub 2021 Oct 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cerebrospinal Fluid
  • Circulating Tumor DNA* / genetics
  • Flow Cytometry
  • Humans
  • Lymphoma, Non-Hodgkin*
  • Spinal Cord

Substances

  • Circulating Tumor DNA